Select Page
nonconforming materials report

ALCOA: A Data Integrity Standard

For many years, data integrity has been of particular concern to both industry and global regulatory authorities. Data integrity requirements have increased, especially with the advent of new technologies and their need for rapid application to support development of new drugs and vaccines, manufacturing operations, and beyond. This rapid inclusion in the industry has resulted in an increase in data integrity observations issued from different regulatory bodies, resulting in warning letters and ending in legal investigations. The purpose of this White Paper is to discuss ALCOA as a methodology to implement data integrity processes in support of product quality and safety, as well as to avoid observation issuance from regulatory authorities.

Download your FREE White Paper!


* These fields are required.

FOLLOW PATHWISE!

CHECK OUT OTHER PATHWISE WHITE PAPERS!

Role-Based Training in Investigations and CAPA: Supporting Quality in Medical Device and Pharmaceutical Manufacturing

In the highly regulated environments of medical device and pharmaceutical manufacturing, ensuring...

White Paper: What’s the Right Number of CAPAs?

Spoiler alert- it’s not an exact number, and that number isn’t zero. The right number of CAPAs...

Key Performance Indicators for Life Science

Key Performance Indicators for Life Science The number of possible KPIs is endless. It all depends...

Free Download! Top 483 Observations from 2022

Top FDA 483 Warning Letter Observations from 2019 for Medical Device, Drugs, and Biologics Every...